Sort   by:  
 Page size 
UnknownPersistence of immunity and impact of third dose of inactivated COVID-19 vaccine against emerging variants.
Not available
S-EPMC9281359 | biostudies-literature
UnknownImmunogenicity and reactogenicity of an inactivated SARS-CoV-2 vaccine (BBV152) in children aged 2-18 years: interim data from an open-label, non-randomised, age de-escalation phase 2/3 study.
Not available
S-EPMC9212880 | biostudies-literature
UnknownHealthcare access and utilisation trends among the elderly in India: Evidence from the LASI Wave-1 survey.
Not available
S-EPMC12398264 | biostudies-literature
UnknownCost of Surgical Care at Public Sector District Hospitals in India: Implications for Universal Health Coverage and Publicly Financed Health Insurance Schemes.
Not available
S-EPMC9216290 | biostudies-literature
UnknownPhase I Clinical Trial of a Recombinant Blood Stage Vaccine Candidate for Plasmodium falciparum Malaria Based on MSP1 and EBA175.
Not available
S-EPMC4415778 | biostudies-literature
UnknownTransforming Hospital Housekeeping: The Kayakalp Journey.
Not available
S-EPMC11554396 | biostudies-literature
UnknownHumoral and cellular immune response to AZD1222 /Covishield and BV152/Covaxin COVID-19 vaccines among adults in India.
Not available
S-EPMC11497953 | biostudies-literature
UnknownUsing a national level cross-sectional study to develop a Hospital Preparedness Index (HOSPI) for Covid-19 management: A case study from India.
Not available
S-EPMC9328545 | biostudies-literature
UnknownEstablishing reference costs for the health benefit packages under universal health coverage in India: cost of health services in India (CHSI) protocol.
Not available
S-EPMC7375634 | biostudies-literature
UnknownSafety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: a double-blind, randomised, phase 1 trial.
Not available
S-EPMC7825810 | biostudies-literature
Sort   by:  
 Page size